Efficacy Section Copy
-
Significant improvement needs to be substantiated with clinical significance, e.g., HR values, p-value (see PAAB code s.3.1.1). Please also indicate that this is a primary endpoint.
As a reminder, anything referenced in this APS must be reviewed before dissemination. Kindly disclose the eFiles for the materials in the FLEX campaign that you are referring the physicians to.